# Vitalant – FDA Inspection, Mar 2, 2026

Source: https://www.keypedia.com/records/fda_inspections/vitalant/f7653b44-05a2-40bb-8156-9bd029eeb127
Source feed: FDA_Inspections

> FDA inspection 1305116 of Vitalant, March 02, 2026. 3 citations under 21 CFR parts 606 and 640. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305116
- Company Name: Vitalant
- Inspection Date: 2026-03-02
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Denver District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1194288 - 2022-12-07
- FDA Inspection 1075127 - 2018-10-23
- FDA Inspection 998084 - 2016-12-08
- FDA Inspection 913511 - 2015-02-10
- FDA Inspection 857599 - 2013-12-03

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/conor-j-mccarron/280401e4-b080-4ba8-ab35-d3b16e91c2b1)

Company: https://www.keypedia.com/companies/vitalant/d2f04f9b-f026-4fe6-af57-a4a0dd4a97fa

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face